MBL-II-141
MBL-II-141 is a potent ABCG2 inhibitor with an IC50 of 0.11 μM. It inhibits the transport function of ABCG2 in a non-competitive manner, preventing ABCG2 from expelling substrates (such as Irinotecan) out of cells, thereby increasing the intracellular accumulation of the drug. MBL-II-141 does not affect ABCB1 (P-gp) or ABCC1 (MRP1) and exhibits very low cytotoxicity (IG50 > 100 μM) . This compound is useful for studying tumor multidrug resistance (MDR) .
Product Specifications
CAS Number
1353747-12-2
Smiles
O=C1C=C (OC2=CC=CC (OCC3=CC=C (Br) C=C3) =C12) C (=O) NCCC4=CNC=5C=CC (OC) =CC54
Molecular Formula
C28H23BrN2O5
Molecular Weight
547.41
Storage Conditions
-20°C
Notes
For research use only.
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
BNC471825-500 1x 500 µL
Gp100 / Melanosome / PMEL17 / SILV (Melanoma Marker) (PMEL/1825R), CF647 conjugate, 0.1mg/mL
Sign In for Pricing
View Details 
BNC681190-500 1x 500 µL
Cytokeratin 18 (KRT18/1190), CF568 conjugate, 0.1mg/mL
Sign In for Pricing
View Details